GlobalData’s clinical trial report, “Mild Cognitive Impairment Global Clinical Trials Review, H1, 2014” provides data on the Mild Cognitive Impairment clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Mild Cognitive Impairment. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Mild Cognitive Impairment. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

• Understand the dynamics of a particular indication in a condensed manner
• Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
• Obtain discontinued trial listing for trials across the globe
• Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Mild Cognitive Impairment 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Mild Cognitive Impairment to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Mild Cognitive Impairment to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Mild Cognitive Impairment 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Mild Cognitive Impairment Therapeutics Clinical Trials 32
Prominent Drugs 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
Pfizer Inc. 35
Clinical Trial Overview of Pfizer Inc. 35
Novartis AG 36
Clinical Trial Overview of Novartis AG 36
Johnson & Johnson 37
Clinical Trial Overview of Johnson & Johnson 37
Eisai Co., Ltd. 38
Clinical Trial Overview of Eisai Co., Ltd. 38
Posit Science Corporation 39
Clinical Trial Overview of Posit Science Corporation 39
Merck & Co., Inc. 40
Clinical Trial Overview of Merck & Co., Inc. 40
General Electric Company 41
Clinical Trial Overview of General Electric Company 41
Dr. Willmar Schwabe Pharmaceuticals 42
Clinical Trial Overview of Dr. Willmar Schwabe Pharmaceuticals 42
Chiesi Farmaceutici SpA 43
Clinical Trial Overview of Chiesi Farmaceutici SpA 43
Clinical Trial Overview of Top Institutes / Government 44
University of Washington 44
Clinical Trial Overview of University of Washington 44
U.S. Department of Veterans Affairs 45
Clinical Trial Overview of U.S. Department of Veterans Affairs 45
National Institute on Aging 46
Clinical Trial Overview of National Institute on Aging 46
University Hospital, Angers 47
Clinical Trial Overview of University Hospital, Angers 47
Charite - Universitatsmedizin Berlin 48
Clinical Trial Overview of Charite - Universitatsmedizin Berlin 48
Vanderbilt University 49
Clinical Trial Overview of Vanderbilt University 49
University Hospital Basel 50
Clinical Trial Overview of University Hospital Basel 50
National Institute of Mental Health 51
Clinical Trial Overview of National Institute of Mental Health 51
Johns Hopkins University 52
Clinical Trial Overview of Johns Hopkins University 52
Emory University 53
Clinical Trial Overview of Emory University 53
Five Key Clinical Profiles 54
Appendix 81
Abbreviations 81
Definitions 81
Research Methodology 82
Secondary Research 82
About GlobalData 83
Contact Us 83
Disclaimer 83
Source 83

List of Tables

Mild Cognitive Impairment Therapeutics, Global, Clinical Trials by Region, 2014* 7
Mild Cognitive Impairment Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Mild Cognitive Impairment Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Mild Cognitive Impairment Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Mild Cognitive Impairment Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Mild Cognitive Impairment Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Mild Cognitive Impairment Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Mild Cognitive Impairment Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Mild Cognitive Impairment to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Mild Cognitive Impairment Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Mild Cognitive Impairment Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Mild Cognitive Impairment to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Mild Cognitive Impairment Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Mild Cognitive Impairment Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Mild Cognitive Impairment Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Mild Cognitive Impairment Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Mild Cognitive Impairment Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Mild Cognitive Impairment Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Mild Cognitive Impairment Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Mild Cognitive Impairment Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Mild Cognitive Impairment Therapeutics, Global, Terminated Clinical Trials, 2014* 27
Mild Cognitive Impairment Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29
Mild Cognitive Impairment Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 30
Mild Cognitive Impairment Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 31
Mild Cognitive Impairment Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 33
Mild Cognitive Impairment Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 34
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 35
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 36
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014* 37
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2014* 38
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Posit Science Corporation, 2014* 39
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 40
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by General Electric Company, 2014* 41
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Willmar Schwabe Pharmaceuticals, 2014* 42
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiesi Farmaceutici SpA, 2014* 43
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014* 44
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014* 45
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute on Aging, 2014* 46
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Angers, 2014* 47
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite - Universitatsmedizin Berlin, 2014* 48
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2014* 49
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2014* 50
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health, 2014* 51
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2014* 52
Mild Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2014* 53

List of Figures

Mild Cognitive Impairment Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Mild Cognitive Impairment Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Mild Cognitive Impairment Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Mild Cognitive Impairment Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Mild Cognitive Impairment Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Mild Cognitive Impairment Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Mild Cognitive Impairment Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Mild Cognitive Impairment Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Mild Cognitive Impairment to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Mild Cognitive Impairment Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Mild Cognitive Impairment Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Mild Cognitive Impairment to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Mild Cognitive Impairment Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Mild Cognitive Impairment Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Mild Cognitive Impairment Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Mild Cognitive Impairment Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Mild Cognitive Impairment Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Mild Cognitive Impairment Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Mild Cognitive Impairment Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29
Mild Cognitive Impairment Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 30
Mild Cognitive Impairment Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 31
Mild Cognitive Impairment Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 32
Mild Cognitive Impairment Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 34
GlobalData Methodology 82